ArticleJournal of the American Chemical Society2025
Catalytic Enantioselective Perezone-Type [5 + 2] Cycloaddition.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pipitzols and Isopipitzols, 1852 to 2026: A Review.Molecules (Basel, Switzerland) · 2026Review
- Regioselective Synthesis of Methyl Enol Ethers from Cycloalkanones via O-Methylation of Kinetic Enolates.Synthesis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here we report the first catalytic enantioselective Perezone-type [5 + 2] cycloaddition, enabling convenient access to a variety of bicyclo[3.2.1]octanes and other complex carbocycles from readily available quinone ketals and alkenes. Enabled by a new chiral squaramide catalyst, intermolecular C-C bond formation was achieved with excellent enantio- and diastereoselectivities. The highly enantioenriched and densely functionalized products can be transformed into diverse intriguing complex carbocycles that may not be straightforward to access by conventional methods. Mechanistic studies and DFT studies provided important insights into the mechanism, in which substrate solvation is a rate-limiting step, while C-C bond formation is fast and stepwise. Activation of the Lewis acid TESOTf by the chiral hydrogen bond donor catalyst is crucial not only for substrate activation and solvation but also for enantiocontrol via the catalyst-bound chiral counter anion.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.